Narrated intraoperative walk-through with a master surgeon
Q&A with Steven Nissen on the advent of diabetes drugs that curb cardiac events
Review calls for consideration of novel assessment variables
Dr. Steven Nissen shares why these studies matter
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic cardiologist shares key takeaways
A push for prolonged rhythm monitoring — and more thorough workup
Meta-analysis proves its value, but patient risk defines its role
Perspectives from two veteran vascular surgeons
An expert Q&A on degeneration findings from EuroPCR
Lead investigator shares registry highlights, implications
Advertisement
Advertisement